Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Bluebird’s Zynteglo Launch Under Way, But First Revenue Will Take Months
First Sales Of Newly Approved Product Expected In Q1 2023
Aug 18 2022
•
By
Mandy Jackson
Manufacturing and quality control will take 70-90 days for each Zynteglo dose • Source: Shutterstock
More from New Products
More from Scrip